Posts by author
Marc Beishon
12 posts
Real world data: can we rely on it to shape cancer policies and practice?
In November 2018, the US Food and Drug Administration granted accelerated approval to larotrectinib (Vitrakvi), a drug that targets a neurotrophic receptor tyrosine kinase (NTRK) gene fusion in a range of adult and paediatric tumours. European approval followed last autumn.…
Lynn Faulds Wood: consumer rights watchdog who took up the cause of cancer patients
Many tributes have been paid to Lynn Faulds Wood, the co-founder and first president of the European Cancer Patient Coalition (ECPC), who has died aged 72. She had a profound influence on giving voice to European cancer patients and advocates…